A detailed history of Verition Fund Management LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Verition Fund Management LLC holds 18,829 shares of ACAD stock, worth $277,539. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,829
Holding current value
$277,539
% of portfolio
0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$14.62 - $18.42 $275,279 - $346,830
18,829 New
18,829 $305,000
Q2 2023

Aug 14, 2023

BUY
$17.8 - $25.65 $274,600 - $395,702
15,427 New
15,427 $369,000
Q2 2022

Aug 15, 2022

BUY
$13.01 - $27.22 $153,426 - $321,005
11,793 New
11,793 $166,000
Q4 2021

Feb 14, 2022

SELL
$16.79 - $27.09 $168,504 - $271,875
-10,036 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$15.78 - $24.77 $158,368 - $248,591
10,036 New
10,036 $167,000
Q4 2020

Feb 16, 2021

SELL
$41.04 - $56.79 $246,075 - $340,512
-5,996 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$36.42 - $57.0 $1.13 Million - $1.77 Million
-31,121 Reduced 83.85%
5,996 $247,000
Q2 2020

Aug 14, 2020

BUY
$39.26 - $52.73 $1.46 Million - $1.96 Million
37,117 New
37,117 $1.8 Million
Q1 2020

May 15, 2020

SELL
$31.65 - $46.87 $1.29 Million - $1.9 Million
-40,605 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$36.21 - $51.4 $956,125 - $1.36 Million
26,405 Added 185.95%
40,605 $1.74 Million
Q3 2019

Nov 14, 2019

SELL
$22.22 - $44.01 $1.05 Million - $2.08 Million
-47,174 Reduced 76.86%
14,200 $511,000
Q2 2019

Aug 14, 2019

BUY
$23.32 - $28.12 $1.43 Million - $1.73 Million
61,374 New
61,374 $1.64 Million
Q3 2018

Nov 15, 2018

SELL
$13.03 - $21.81 $139,355 - $233,257
-10,695 Closed
0 $0
Q2 2018

Aug 15, 2018

BUY
$15.07 - $22.34 $161,173 - $238,926
10,695 New
10,695 $163,000
Q4 2017

Feb 15, 2018

SELL
$26.84 - $39.14 $247,384 - $360,753
-9,217 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$29.49 - $38.37 $271,809 - $353,656
9,217
9,217 $347,000

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.39B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.